Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Neurosci.

Sec. Gut-Brain Axis

Volume 19 - 2025 | doi: 10.3389/fnins.2025.1602681

This article is part of the Research TopicNew Insights into Pediatric Neurodevelopmental Disorders: Autism Spectrum Disorder and its ComorbiditiesView all articles

Does Constipation affect the effectiveness of Washed Microbiota Transplantation in treating Autism Spectrum Disorders?

Provisionally accepted
Zihao  PanZihao Pan1Zheng  GaoZheng Gao1Junyi  ChenJunyi Chen1Yongxi  QuanYongxi Quan1Jiating  XuJiating Xu2Xiaofeng  LiangXiaofeng Liang1Wenrui  XieWenrui Xie1Xingxiang  HeXingxiang He1,2*Lihao  WuLihao Wu1,2*
  • 1The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China
  • 2Research Center for Engineering Techniques of Microbiota-Targeted Therapies of Guangdong Province, Guangzhou, China

The final, formatted version of the article will be published soon.

Purpose: Washed Microbiota Transplantation (WMT) has been shown to improve the symptoms of Autism Spectrum Disorder (ASD). It's currently unclear whether the presence of constipation affects the efficacy of WMT in children with ASD. This study aims to investigate whether constipation affects the efficacy of WMT in children with ASD.Patients and methods: To investigate the efficacy of WMT for ASD, we conducted a retrospective analysis of changes in ASD-related symptoms, sleep disturbances, gastrointestinal manifestations, intestinal barrier integrity, and gut microbiota composition in 103 ASD patients undergoing WMT. They were divided into two groups according to whether constipation was present or not before treatment.Results: 1. Aberrant Behavior Checklist (ABC), Childhood Autism Rating Scale (CARS), and Sleep Disturbance Scale for Children (SDSC) scores in the non-constipation and constipation groups decreased with an increase in the number of WMT treatments.2. Comparison of two groups: ABC scores in the non-constipation group decreased more after the first WMT course, whereas ABC scores in the constipation group decreased more after two WMT courses.3. Intestinal Barrier Function: D-lactate levels decreased more in the constipation group after the first two courses. In general, WMT treatment had no significant effect on intestinal barrier function in patients with ASD. 4. Effect of WMT on constipation: As the number of WMT courses increased, Bristol Stool Form Scale (BSFS) scores in constipation group gradually approached 4. 5. Constipation group had lower microbial diversity than non-constipation group at baseline. After one course of WMT, constipation group showed an obvious increase in microbial diversity and a significant increase in the relative abundance of Bifidobacteria compared to non-constipation group.Conclusion: Post WMT, core symptoms and sleep disorders were significantly improved in both groups. Feces returned to normal shape in the constipation group. A difference in efficacy between the two groups was observed in early stages, but after multiple courses of WMT no difference in efficacy was noted. Although in the short-term, children with ASD and comorbid constipation showed a significant increase in microbial diversity after receiving WMT, mid-term outcomes indicate that constipation does not affect the efficacy of WMT in treating ASD.

Keywords: washed microbiota transplantation, autism, clinical efficacy, Constipation, Sleep Disorders, intestinal barrier function

Received: 31 Mar 2025; Accepted: 30 Jun 2025.

Copyright: © 2025 Pan, Gao, Chen, Quan, Xu, Liang, Xie, He and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Xingxiang He, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China
Lihao Wu, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.